These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19808275)

  • 1. Challenges for the basis of practice in heart failure.
    Stevenson LW
    Circ Heart Fail; 2008 May; 1(1):81-3. PubMed ID: 19808275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition.
    Zannad F; Stough WG; Pitt B; Cleland JG; Adams KF; Geller NL; Torp-Pedersen C; Kirwan BA; Follath F
    Eur Heart J; 2008 Feb; 29(3):413-21. PubMed ID: 18245122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Blocker therapy for congestive heart failure: clinical considerations.
    Kamath SA; Yancy CW
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):12-20. PubMed ID: 19667706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future is here: ventricular assist devices for the failing heart.
    Alba AC; Delgado DH
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1067-77. PubMed ID: 19764860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waltz dancing in patients with chronic heart failure: new form of exercise training.
    Belardinelli R; Lacalaprice F; Ventrella C; Volpe L; Faccenda E
    Circ Heart Fail; 2008 Jul; 1(2):107-14. PubMed ID: 19808280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
    Hradec J; Krupicka J; Janota T
    Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights of the 2008 Scientific Sessions of the Heart Failure Society of America. Toronto, Ontario, Canada, September 20-23, 2008.
    Mehra MR; Rockman HA; Greenberg BH
    J Am Coll Cardiol; 2009 Feb; 53(6):514-22. PubMed ID: 19195609
    [No Abstract]   [Full Text] [Related]  

  • 11. Left ventricular assist devices: psychosocial challenges in the elderly.
    Marcus P
    Ann Thorac Surg; 2009 Nov; 88(5):e48-9. PubMed ID: 19853075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spiritual well-being, spiritual practices, and depressive symptoms among elderly patients hospitalized with acute heart failure.
    Whelan-Gales MA; Quinn Griffin MT; Maloni J; Fitzpatrick JJ
    Geriatr Nurs; 2009; 30(5):312-7. PubMed ID: 19818266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device-guided paced breathing in the home setting: effects on exercise capacity, pulmonary and ventricular function in patients with chronic heart failure: a pilot study.
    Parati G; Malfatto G; Boarin S; Branzi G; Caldara G; Giglio A; Bilo G; Ongaro G; Alter A; Gavish B; Mancia G
    Circ Heart Fail; 2008 Sep; 1(3):178-83. PubMed ID: 19808287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony.
    Williams LK; Ellery S; Patel K; Leyva F; Bleasdale RA; Phan TT; Stegemann B; Paul V; Steendijk P; Frenneaux M
    Circulation; 2009 Oct; 120(17):1687-94. PubMed ID: 19822812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death and dying in heart failure with normal ejection fraction.
    Lim HS; Beadle R; Frenneaux M
    Am J Cardiol; 2009 Nov; 104(9):1311-4. PubMed ID: 19840583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of congestion in congestive heart failure: ultrafiltration is the only rational initial treatment of volume overload in decompensated heart failure.
    Bart BA
    Circ Heart Fail; 2009 Sep; 2(5):499-504. PubMed ID: 19808381
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug trials in pediatric heart failure: hype or improved clinical science?
    Shaddy RE
    Future Cardiol; 2006 May; 2(3):281-6. PubMed ID: 19804085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.
    Kandzari DE; Colombo A; Park SJ; Tommaso CL; Ellis SG; Guzman LA; Teirstein PS; Tamburino C; Ormiston J; Stone GW; Dangas GD; Popma JJ; Bass TA;
    J Am Coll Cardiol; 2009 Oct; 54(17):1576-88. PubMed ID: 19833256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
    Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
    Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial and bioartificial liver devices: present and future.
    Carpentier B; Gautier A; Legallais C
    Gut; 2009 Dec; 58(12):1690-702. PubMed ID: 19923348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.